Loading clinical trials...
Loading clinical trials...
A Single-arm, Multicenter, Exploratory Study to Evaluate the Efficacy and Safety of Nab-paclitaxel Combined With Local Therapy in Patients With Small-cell Lung Cancer Receiving Second-line or Subsequent Treatment
Conditions
Interventions
Albumin-bound Paclitaxel Combined with Local Therapy
Albumin-Bound Paclitaxel /nab-Paclitaxel
Start Date
April 6, 2026
Primary Completion Date
January 1, 2028
Completion Date
December 31, 2030
Last Updated
April 23, 2026
NCT07177937
NCT05671510
NCT06043817
NCT06257264
NCT06646276
NCT07144280
Lead Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions